Skip to content

Author

M. Cuzzocrea

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [177Lu]Lu-PSMA Radioligand Therapy

Simple Summary Lutetium-177 prostate-specific membrane antigen radioligand therapy is an effective option for metastatic castration-resistant prostate cancer, yet a substantial proportion of patients progress early and no validated PSMA-PET/CT biomarker is available to identify them before treatment. In 63 patients, we...

M. Cuzzocrea, Giovanna Pecoraro, C. Iacovitti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.